Moleculin Biotech CS (MBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Operating Expenses | 2,591 | 5,458 | 2,637 | 3,394 | 2,404 |
| Operating Income | -2,591 | -5,458 | -2,637 | -3,394 | -2,404 |
| Interest Expense | 0 | 3 | -1 | 0 | 1 |
| Other Income | 553 | 330 | 709 | 208 | -461 |
| Pre-tax Income | -2,038 | -5,131 | -1,927 | -3,186 | -2,866 |
| Net Income Continuous | -2,038 | -5,131 | -1,927 | -3,186 | -2,866 |
| Net Income | $-2,038 | $-5,125 | $-1,927 | $-3,186 | $-2,866 |
| EPS Basic Total Ops | -179.87 | -449.69 | -179.87 | -404.72 | -314.78 |
| EPS Basic Continuous Ops | -170.59 | -445.62 | -185.70 | -391.76 | -313.81 |
| EPS Diluted Total Ops | -179.87 | -449.69 | -179.87 | -404.72 | -314.78 |
| EPS Diluted Continuous Ops | -170.59 | -445.62 | -185.70 | -391.76 | -313.81 |
| EBITDA(a) | $-2,579 | $-5,451 | $-2,629 | $-3,389 | $-2,399 |